Quest Patent Research Corporation announces $3.6 million net income for 2023
RYE, N.Y., March 28, 2024 /PRNewswire/ -- Quest Patent Research Corporation (OTCQB: QPRC) (the "Company" or "Quest"), announced today the results of its operations for the year ended December 31, 2023. For the year ended December 31, 2023, the Company generated net income of approximately $3.6 million, or $0.68 per share (basic and diluted), on revenues of approximately $13.2 million as compared to a loss of approximately $0.8 million on revenues of $0.5 million for the year ended December 31, 2022. Revenue from both years was generated from the settlement of patent infringement litigation. The Company's balance sheet, statement of operations and statements of cash flows are included as exhibits to this press release.
About Quest Patent Research Corporation
Quest is an intellectual property asset management company. Its principal operations include the acquisition, licensing and enforcement of intellectual property rights that are either owned or controlled by the Company. Quest currently owns, controls or manages 22 intellectual property portfolios of which it is currently seeking or may seek monetization with respect to twelve portfolios, which principally consist of patent rights. Quest's business is described in its annual report on Form 10-K for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission on March 28, 2024. Quest's website is www.qprc.com. Information contained on or derived from Quest's website, or any other website or any social media does not constitute a part of this press release.
This press release and the earnings call contain "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, but are not limited to the risk that the Quest may not generate any significant revenue or operate profitably in the future and the other risks described in "Forward Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Quest's Form 10-K for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission on March 28, 2024.
QUEST PATENT RESEARCH CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
December 31,
2023
2022
ASSETS
Current assets
Cash and cash equivalents
$ 563,484
$ 90,601
Accounts receivable, net of allowance for credit losses of $0 and $0, respectively
3,008,250
-
Other current assets
28,121
5,321
Total current assets
3,599,855
95,922
Patents, net of accumulated amortization of $2,412,397 and $1,625,846, respectively
3,674,603
1,131,154
Total assets
$ 7,274,458
$ 1,227,076
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued liabilities
296,536
148,533
Loans payable
138,000
138,000
Funding liability
7,325,502
5,453,204
Loan payable - related party
2,796,500
2,796,500
Warrant liability
281,809
145,428
Accrued interest
1,096,985
904,573
Total current liabilities
11,935,332
9,586,238
Non-current liabilities
Loan payable - SBA
150,000
150,000
Purchase price of patents
53,665
53,665
Total liabilities
12,138,997
9,789,903
Commitments and contingencies (Note 10)
Stockholders' deficit:
Preferred stock, par value $0.00003 per share - authorized 10,000,000 shares - no shares issued and outstanding
-
-
Common stock, par value $0.00003 per share; authorized 30,000,000 at December 31, 2023 and 2022; 5,331,973 shares issued and outstanding at December 31, 2023 and December 31, 2022
160
160
Additional paid-in capital
17,674,985
17,626,279
Accumulated deficit
(22,539,912)
(26,189,494)
Total Quest Patent Research Corporation stockholders' deficit
(4,864,767)
(8,563,055)
Non-controlling interest in subsidiary
228
228
Total stockholders' deficit
(4,864,539)
(8,562,827)
Total liabilities and stockholders' deficit
$ 7,274,458
$ 1,227,076
QUEST PATENT RESEARCH CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Year Ended December 31,
2023
2022
Revenues
Patent licensing fees
$ 13,152,500
$ 451,194
Cost of revenue
Litigation and licensing expenses
5,534,596
303,671
Gross margin
7,617,904
147,523
Operating expenses
Selling, general and administrative expenses
2,740,554
1,979,718
Total operating expenses
2,740,554
1,979,718
Income (loss) from operations
4,877,350
(1,832,195)
Other income (expense)
Change in fair market value of warrant liability
(136,381)
1,490,759
Interest expense
(1,061,387)
(413,333)
Total other income (expense)
(1,197,768)
1,077,426
Income (loss) before income tax
3,679,582
(754,769)
Income tax benefit (expense)
(30,000)
1,253
Net income (loss)
$ 3,649,582
$ (753,516)
Income (loss) per share - basic and diluted
$ 0.68
$ (0.14)
Weighted average shares outstanding - basic and diluted
5,331,973
5,331,973
QUEST PATENT RESEARCH CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended December 31,
2023
2022
Cash flows from operating activities:
Net income (loss)
$ 3,649,582
$ (753,516)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Change in fair market value of warrant liability
136,381
(1,490,759)
Stock-based compensation
48,706
117,412
Amortization of intangible assets
786,552
910,326
Change in operating assets and liabilities:
Accounts receivable
(3,008,250)
-
Accrued interest
192,415
412,602
Other current assets
(22,800)
6,984
Accounts payable and accrued liabilities
147,999
19,108
Patents loan payable
-
(136,335)
Net cash provided by (used in) operating activities
1,930,585
(914,178)
Cash flows from investing activities:
Purchase of intangible assets
(3,330,000)
(1,502,000)
Net cash used in investing activities
(3,330,000)
(1,502,000)
Cash flows from financing activities:
Payments on loans - related party
-
(8,500)
Proceeds from funding liability
6,000,000
2,303,000
Payment of funding liability
(4,127,702)
(52,561)
Net cash provided by financing activities
1,872,298
2,241,939
Net increase (decrease) in cash and cash equivalents